Patient/Caregiver Update: What's New and What's Next in the Treatment of MDS?

Patients published on April 18, 2019
Download Transcript Download Audio
Begin Evaluation

In this activity, developed by in cooperation with the MDS Foundation, patients with MDS and their caregivers will hear from two key experts about a variety of topics including: personalized risk stratification, iron overload, immunotherapies, and new strategies for treating lower- and higher-risk MDS. Join Dr. Mikkael Sekeres and Dr. David Steensma as they discuss best practices for considering a patient's individual molecular abnormalities into their diagnosis and prognosis, and as they review new treatments that may change the future of MDS treatment.

This activity is supported by educational grants from Astex Pharmaceuticals and Celgene Corporation

Last modified: April 19, 2019

MediCom Worldwide, Inc. would like to thank Celgene Corporation and Onconova Therapeutics Inc. for their educational support of

©2020 MediCom Worldwide, Inc. All rights reserved